Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bristol-Myers Squibb Partners To Expand Diabetes Franchise In China

Mar 26 2013

• By Jialing Dai

Related Content

Lyxumia As Fourth GLP-1 To Market? Not To Worry, Says Zealand CEO

Mar 19 2013

Bristol Signals Dapaglifozin’s Back On Track, Plans FDA Resubmission

Nov 01 2012

AstraZeneca, BMY To Target Disease Management And Primary Care Synergies With Amylin Acquisition

Jul 03 2012

Related Companies

Bristol Myers Squibb Company

Merck KGaA

Bayer AG

Novo Nordisk A/S

Eli Lilly and Company

AstraZeneca PLC

Bristol Myers Squibb Company

Merck & Co., Inc.

Sanofi

Novartis AG

Boehringer Ingelheim GmbH

Zealand Pharma A/S

Johnson & Johnson

Additional Topics

China Asia Pacific Emerging Markets Approvals BioPharmaceutical

More from China

More from Focus On Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window